Tuberculosis - Pataskia Flashcards
TB progression in relation to testing: active TB disease
TST: usually +
IGRA: usually +
culture: +
sputum smear: + or -
infectious: yes
sx: mild-severe
preferred treatment: multidrug therapy
TB progression in relation to testing: subclinical TB disease
TST: +
IGRA: +
culture: intermittently +
sputum smear: usually -
infectious: sporadically
sx: mild or none
preferred treatment: multidrug therapy
TB progression in relation to testing: latent TB infection
TST: +
IGRA: +
culture: -
sputum smear: -
infectious: no
sx: none
preferred treatment: preventive therapy
TB progression in relation to testing: infection eliminated with acquired immune response
TST: +
IGRA: +
culture: -
sputum smear: -
infectious: no
sx: none
preferred treatment: none
TB progression in relation to testing: infection eliminated with innate immune response
TST: -
IGRA: -
culture: -
sputum smear: -
infectious: no
sx: none
preferred treatment: none
Which LTBI medication would you typically want to avoid or be cautious with in pts living with HIV?
rifampin
What is drug susceptible TB?
TB strains that are sensitive to the standard 1st line agents
What is monoresistant TB?
TB strains that are sensitive to just one anti-TB drug
What is polyresistant TB?
TB strains that are resistant to more than one anti-TB drug but not INH (isoniazid) and RIF (rifampin)
What is multidrug resistant TB?
TB strains that are resistant to RIF and INH
What is extensively drug-resistant TB?
TB strains that are resistant to RIF and INH + at least one injectable agent (amikacin, kanamycin, or capreomyci) + any of the FQs
What is the treatment of drug susceptible TB? - standard 6mo treatment
intensive phase: rifampin 600mg + isoniazid 300mg + ethambutol 800-1600mg + pyrazinamide 1000-2000mg once/day x 8 weeks
continuation phase: rifampin 600mg + isoniazide 300mg once/day x 18 weeks
What is the treatment of drug susceptible TB? - 4mo treatment
intensive phase: rifapentine 1200mg + isoniazid 300mg + moxifloxacin 400mg + pyrazinamide 1000-2000mg once/day x 8 weeks
continuation phase: rifapentine 1200mg + isoniazid 300mg + moxifloxacin 400mg once/day x9 weeks